BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9465046)

  • 21. Roles of p53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor.
    Liu X; Zhu XZ
    Brain Res Mol Brain Res; 1999 Aug; 71(2):210-6. PubMed ID: 10521575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.
    Qing G; Li B; Vu A; Skuli N; Walton ZE; Liu X; Mayes PA; Wise DR; Thompson CB; Maris JM; Hogarty MD; Simon MC
    Cancer Cell; 2012 Nov; 22(5):631-44. PubMed ID: 23153536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediation of c-Myc-induced apoptosis by p53.
    Hermeking H; Eick D
    Science; 1994 Sep; 265(5181):2091-3. PubMed ID: 8091232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence from transgenic mice that myc regulates hepatic glycolysis.
    Valera A; Pujol A; Gregori X; Riu E; Visa J; Bosch F
    FASEB J; 1995 Aug; 9(11):1067-78. PubMed ID: 7649406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A.
    Lewis BC; Prescott JE; Campbell SE; Shim H; Orlowski RZ; Dang CV
    Cancer Res; 2000 Nov; 60(21):6178-83. PubMed ID: 11085542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
    Kobzdej M; Matuszyk J; Strzadala L
    Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle.
    Ryan JJ; Prochownik E; Gottlieb CA; Apel IJ; Merino R; Nuñez G; Clarke MF
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5878-82. PubMed ID: 8016082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway.
    Rogulski K; Li Y; Rothermund K; Pu L; Watkins S; Yi F; Prochownik EV
    Oncogene; 2005 Nov; 24(51):7524-41. PubMed ID: 16170375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.
    Coloff JL; Mason EF; Altman BJ; Gerriets VA; Liu T; Nichols AN; Zhao Y; Wofford JA; Jacobs SR; Ilkayeva O; Garrison SP; Zambetti GP; Rathmell JC
    J Biol Chem; 2011 Feb; 286(7):5921-33. PubMed ID: 21159778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
    Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
    Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of c-myc-transformed rat fibroblasts resistant to apoptosis induced ny growth factor deprivation.
    Dhanaraj SN; Marcus AM; Korah RM; Iwata K; Small MB
    Exp Cell Res; 1996 Apr; 224(1):52-62. PubMed ID: 8612691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest.
    Guillouf C; Graña X; Selvakumaran M; De Luca A; Giordano A; Hoffman B; Liebermann DA
    Blood; 1995 May; 85(10):2691-8. PubMed ID: 7742528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Wang Y; Szekely L; Okan I; Klein G; Wiman KG
    Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
    Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
    Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc.
    Osthus RC; Shim H; Kim S; Li Q; Reddy R; Mukherjee M; Xu Y; Wonsey D; Lee LA; Dang CV
    J Biol Chem; 2000 Jul; 275(29):21797-800. PubMed ID: 10823814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of induction of tissue transglutaminase but activation of the preexisting enzyme in c-Myc-induced apoptosis of CHO cells.
    Balajthy Z; Kedei N; Nagy L; Davies PJ; Fésüs L
    Biochem Biophys Res Commun; 1997 Jul; 236(2):280-4. PubMed ID: 9240425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.